Skip to main content
Pharnext logo

Pharnext — Investor Relations & Filings

Ticker · ALPHA ISIN · FR0011191287 LEI · 969500KJGF9ZUYXSMJ27 Euronext Growth Manufacturing
Filings indexed 382 across all filing types
Latest filing 2022-10-17 Earnings Release
Country FR France
Listing Euronext Growth ALPHA

About Pharnext

https://pharnext.com/

Pharnext is an advanced clinical-stage biopharmaceutical company that develops novel therapeutics for neurodegenerative diseases lacking curative or satisfactory treatments. The company's approach is based on its proprietary Pleotherapy™ platform, which uses network pharmacology to identify and develop synergistic combinations of already-approved drugs at new, lower doses. This strategy aims to create more effective and safer treatments. Pharnext's lead product candidate, PXT3003, is an oral fixed-dose combination therapy in development for the treatment of Charcot-Marie-Tooth disease type 1A (CMT1A), a rare, debilitating inherited peripheral neuropathy.

Recent filings

Filing Released Lang Actions
Pharnext Reports First Half 2022 Financial Results
Earnings Release Classification · 1% confidence The document is a press release announcing the financial results for the first half of 2022. It contains a summary table of financial information (revenue, operating results, net income, cash flow) and management commentary on business trends and outlook. While it provides financial data, it is an announcement of the results rather than the full, comprehensive interim report itself, as evidenced by the explicit statement: 'Complete financial statements are available on the Pharnext website'. According to the 'Menu vs Meal' rule, this is classified as an Earnings Release (ER). H1 2022
2022-10-17 English
Pharnext annonce ses résultats financiers du 1er semestre 2022
Earnings Release Classification · 1% confidence The document is titled "Pharnext annonce ses résultats financiers du 1er semestre 2022" (Pharnext announces its financial results for the 1st half of 2022). It contains detailed financial tables (revenues, operating result, net result, cash flow) for the first half of 2022 compared to 2021, along with management commentary on R&D progress and financing. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year (six months). Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is comprehensive, not just highlights, and it is not a 10-K as it covers only the first half of the year. H1 2022
2022-10-17 French
Pharnext Reports First Half 2022 Financial Results
Earnings Release Classification · 1% confidence The document is a press release announcing the financial results for the first half of 2022. It contains a summary table of financial information (revenue, operating results, net income, cash flow) and management commentary on business trends and outlook. While it provides financial data, it is an announcement of the results rather than the full, comprehensive interim report itself, as evidenced by the explicit statement: 'Complete financial statements are available on the Pharnext website'. According to the 'Menu vs Meal' rule, this is classified as an Earnings Release (ER). H1 2022
2022-10-17 English
Pharnext annonce ses résultats financiers du 1er semestre 2022
Earnings Release Classification · 1% confidence The document is titled "Pharnext annonce ses résultats financiers du 1er semestre 2022" (Pharnext announces its financial results for the 1st half of 2022). It contains detailed financial tables (revenues, operating result, net result, cash flow) for the first half of 2022 compared to 2021, along with management commentary on R&D progress and financing. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year (six months). Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is comprehensive, not just highlights, and it is not a 10-K as it covers only the first half of the year. H1 2022
2022-10-17 French
Pharnext announces a reverse stock split and suspension of the right to exercise all the securities giving access to Pharnext's share capital including the conversions of convertible bonds
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces a 'reverse stock split' and the 'suspension of the right to exercise all the securities giving access to Pharnext's share capital'. This action directly relates to a change in the company's capital structure, specifically the number and nominal value of its shares. Reviewing the definitions, the 'Share Issue/Capital Change' (SHA) category is the most appropriate fit for corporate actions involving stock splits or significant changes to the share count. The document is a formal announcement detailing the mechanics and timetable of this capital structure change.
2022-10-03 English
Pharnext annonce le regroupement de ses actions et la suspension de la faculté d’exercer les valeurs mobilières donnant accès au capital en ce compris les conversions d’obligations convertibles
Share Issue/Capital Change Classification · 1% confidence The document is a press release from Pharnext announcing a share consolidation (regroupement d'actions) and the suspension of the right to exercise securities convertible into capital. This action directly relates to the company's capital structure and share count. Based on the definitions, the most appropriate category for an announcement detailing changes to the capital structure, such as a share consolidation, is 'Capital/Financing Update' (CAP). While it involves shares, it is a structural change rather than a simple buyback (POS) or a general share issue (SHA), and it is a specific corporate action announcement, fitting well under CAP.
2022-10-03 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.